Free Trial

This company has been marked as potentially delisted and may not be actively trading.

FS Development (FSDC) Competitors

FS Development logo

FSDC vs. GMTX, CALT, ZYME, CMRX, CDMO, MENS, SBTX, MBX, RVNC, and CKPT

Should you be buying FS Development stock or one of its competitors? The main competitors of FS Development include Gemini Therapeutics (GMTX), Calliditas Therapeutics AB (publ) (CALT), Zymeworks (ZYME), Chimerix (CMRX), Avid Bioservices (CDMO), Jyong Biotech (MENS), Silverback Therapeutics (SBTX), MBX Biosciences (MBX), Revance Therapeutics (RVNC), and Checkpoint Therapeutics (CKPT).

FS Development vs. Its Competitors

Gemini Therapeutics (NASDAQ:GMTX) and FS Development (NASDAQ:FSDC) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

75.4% of Gemini Therapeutics shares are owned by institutional investors. Comparatively, 89.8% of FS Development shares are owned by institutional investors. 12.9% of Gemini Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Gemini TherapeuticsN/AN/A-$71.87M-$1.00-54.75
FS DevelopmentN/AN/AN/AN/AN/A

In the previous week, Gemini Therapeutics' average media sentiment score of 0.00 equaled FS Development'saverage media sentiment score.

Company Overall Sentiment
Gemini Therapeutics Neutral
FS Development Neutral

FS Development's return on equity of 0.00% beat Gemini Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Gemini TherapeuticsN/A -38.78% -35.88%
FS Development N/A N/A N/A

Summary

FS Development beats Gemini Therapeutics on 3 of the 4 factors compared between the two stocks.

Get FS Development News Delivered to You Automatically

Sign up to receive the latest news and ratings for FSDC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FSDC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FSDC vs. The Competition

MetricFS DevelopmentPharmaceutical Preparations IndustryMedical SectorNASDAQ Exchange
Market Cap$685.25M$784.70M$5.45B$8.93B
Dividend YieldN/A4.84%5.22%4.01%
P/E RatioN/A1.3027.2420.06
Price / SalesN/A230.50426.37117.54
Price / CashN/A23.4426.2128.59
Price / BookN/A6.237.925.56
Net IncomeN/A-$27.94M$3.17B$248.56M

FS Development Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FSDC
FS Development
N/A$54.75
+3.0%
N/A+17.4%$685.25MN/A0.00N/A
GMTX
Gemini Therapeutics
N/A$51.13
-3.5%
N/A+17.4%$2.22BN/A-51.1330
CALT
Calliditas Therapeutics AB (publ)
N/A$40.00
flat
N/AN/A$1.19B$1.60B-21.62180
ZYME
Zymeworks
2.0528 of 5 stars
$12.89
+3.9%
$21.00
+62.9%
+44.5%$896.85M$93.38M-8.59460
CMRX
Chimerix
0.6276 of 5 stars
$8.54
flat
$8.53
-0.1%
N/A$801.09M$212K-9.0990
CDMO
Avid Bioservices
0.6885 of 5 stars
$12.50
+0.1%
$12.25
-2.0%
+68.4%$799.18M$139.91M-5.23320High Trading Volume
MENS
Jyong Biotech
N/A$9.62
+13.4%
N/AN/A$731.41MN/A0.0031High Trading Volume
SBTX
Silverback Therapeutics
N/A$16.09
-7.8%
N/A+81.5%$580.17MN/A-6.6583High Trading Volume
MBX
MBX Biosciences
3.0678 of 5 stars
$12.33
+6.2%
$37.50
+204.1%
N/A$412.12MN/A0.0036
RVNC
Revance Therapeutics
2.7508 of 5 stars
$3.65
flat
$8.45
+131.5%
N/A$381.02M$234.04M-1.89500
CKPT
Checkpoint Therapeutics
0.423 of 5 stars
$4.26
flat
$4.33
+1.7%
N/A$370.71M$41K-2.3210

Related Companies and Tools


This page (NASDAQ:FSDC) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners